作者: Garrett Coman , Nicholas Blickenstaff , Howard I. Maibach
DOI: 10.1007/978-1-4939-1289-6_20
关键词:
摘要: Demonstration of bioequivalence can be helpful in a variety situations, including regulatory assessment generic drug formulations and determining equivalent dosing. Finding universally standard method measuring topical has eluded dermatology to date. This paper offers the reader selected examples advances creative insights into clinical endpoints attempts at bioequivalence, giving historical understanding current state with view towards future.